Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China

OBJECTIVE: Clopidogrel is widely used for preventing ischemic complications related to cardiovascular diseases. However, many patients experience clopidogrel resistance (CR). The polymorphisms of CYP2C19 have been implicated in CR, but CYP2C19 polymorphism considerably varies with both ethnic group...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Rong, Zhou, Wenqin, Ye, Yi, Zhang, Xiaofei, Liu, Yanmin, Wu, Jinchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616677/
https://www.ncbi.nlm.nih.gov/pubmed/36325266
http://dx.doi.org/10.1155/2022/1901256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616677/
https://www.ncbi.nlm.nih.gov/pubmed/36325266
http://dx.doi.org/10.1155/2022/1901256

Ejemplares similares